π΅οΈ Recursion Pharmaceuticals, Inc. ($RXRX)
SEC insider & ownership activity, last 12 months Β· CIK 1601830 Β· every row links its SEC filing
Over the last 12 months insiders sold $8.9M with no open-market buying against it. Borgeson Blake sold $4.1M through a 10b5-1 trading plan in 10 lots (DecβSep). No red-flag 8-Ks in the window.
π¨ 2 signals active β
planned-vs-executed verdicts, pre-event flags, and cluster context live in the
API and the
alerts bot.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) Β· 5 sellers, $8.9M (36 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Borgeson Blake | 0 | β | 10 | $4.1M | Sep 1, 2026 |
| Gibson Christopher | 0 | β | 17 | $3.8M | Jun 5, 2026 |
| Khan Najat | 0 | β | 4 | $807K | Sep 8, 2026 |
| Ben R. Taylor | 0 | β | 3 | $158K | Mar 17, 2026 |
| Bumpus Namandje | 0 | β | 2 | $28K | Jun 18, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| BlackRock, Inc. | 8.5% | Class A | 13G | Jul 29, 2026 | filing β |
| ARK Investment Management LLC | 8.5% | 13G | Feb 14, 2025 | filing β | |
| ARK Investment Management LLC | 7.2% | 13G | Feb 3, 2026 | filing β | |
| Catherine D. Wood | 7.2% | 13G | Feb 3, 2026 | filing β | |
| State Street Corporation | 6.6% | 13G | Aug 7, 2026 | filing β | |
| Vanguard Portfolio Management | 6.0% | 13G | Jul 31, 2026 | filing β | |
| Vanguard Capital Management | 5.1% | 13G | Jul 31, 2026 | filing β |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Najat Khan | $79K | Sep 8, 2026 | filing β |
| Borgeson Blake | $100K | Sep 1, 2026 | filing β |
| Gibson Christopher | $262K | Aug 21, 2026 | filing β |
| Gibson Christopher | $255K | Aug 20, 2026 | filing β |
| Gibson Christopher | $328K | Aug 19, 2026 | filing β |
| Gibson Christopher | $80K | Aug 18, 2026 | filing β |
| Gibson Christopher | $331K | Aug 13, 2026 | filing β |
| Gibson Christopher | $168K | Aug 12, 2026 | filing β |
| Gibson Christopher | $327K | Aug 10, 2026 | filing β |
| Gibson Christopher | $325K | Aug 7, 2026 | filing β |
| Borgeson Blake | $98K | Aug 4, 2026 | filing β |
| Gibson Christopher | $245K | Aug 4, 2026 | filing β |
| Gibson Christopher | $225K | Jul 30, 2026 | filing β |
| Gibson Christopher | $151K | Jul 29, 2026 | filing β |
| Gibson Christopher | $153K | Jul 27, 2026 | filing β |
| Gibson Christopher | $304K | Jul 21, 2026 | filing β |
| Gibson Christopher | $290K | Jul 20, 2026 | filing β |
| Gibson Christopher | $297K | Jul 17, 2026 | filing β |
| Gibson Christopher | $311K | Jul 16, 2026 | filing β |
| Gibson Christopher | $410K | Jul 15, 2026 | filing β |
| Gibson Christopher | $330K | Jul 14, 2026 | filing β |
| Gibson Christopher | $343K | Jul 13, 2026 | filing β |
| Gibson Christopher | $354K | Jul 10, 2026 | filing β |
| Gibson Christopher | $1.1M | Jul 9, 2026 | filing β |
| Gibson Christopher | $738K | Jul 8, 2026 | filing β |
| Gibson Christopher | $988K | Jul 7, 2026 | filing β |
| Borgeson Blake | $158K | Jul 7, 2026 | filing β |
| Gibson Christopher | $378K | Jul 6, 2026 | filing β |
| Gibson Christopher | $374K | Jul 2, 2026 | filing β |
| Gibson Christopher | $367K | Jul 1, 2026 | filing β |
| Gibson Christopher | $962K | Jun 18, 2026 | filing β |
| Bumpus Namandje | $13K | Jun 18, 2026 | filing β |
| Gibson Christopher | $127K | Jun 18, 2026 | filing β |
| Gibson Christopher | $145K | Jun 5, 2026 | filing β |
| Najat Khan | $84K | Jun 5, 2026 | filing β |
| Bumpus Namandje | $16K | Jun 3, 2026 | filing β |
| Borgeson Blake | $110K | Jun 2, 2026 | filing β |
| Gibson Christopher | $123K | May 22, 2026 | filing β |
| Gibson Christopher | $135K | May 7, 2026 | filing β |
| Borgeson Blake | $106K | May 5, 2026 | filing β |
| Gibson Christopher | $144K | Apr 22, 2026 | filing β |
| Gibson Christopher | $124K | Apr 7, 2026 | filing β |
| Borgeson Blake | $93K | Apr 7, 2026 | filing β |
| Gibson Christopher | $130K | Mar 23, 2026 | filing β |
| Ben R. Taylor | $27K | Mar 17, 2026 | filing β |
| Najat Khan | $95K | Mar 9, 2026 | filing β |
| Borgeson Blake | $588K | Mar 3, 2026 | filing β |
| Gibson Christopher | $138K | Feb 19, 2026 | filing β |
| Ben R. Taylor | $41K | Feb 18, 2026 | filing β |
| Gibson Christopher | $165K | Feb 4, 2026 | filing β |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Earnings (2.02) | Aug 5, 2026 | filing β |
| Reg FD disclosure (7.01) | Aug 5, 2026 | filing β |
| Financial Statements and Exhibits (9.01) | Aug 5, 2026 | filing β |
| Shareholder vote (5.07) | Jun 17, 2026 | filing β |
| Earnings (2.02) | May 6, 2026 | filing β |
| Reg FD disclosure (7.01) | May 6, 2026 | filing β |
| Financial Statements and Exhibits (9.01) | May 6, 2026 | filing β |
| Officer/director changes (5.02) | Apr 28, 2026 | filing β |
| Reg FD disclosure (7.01) | Apr 28, 2026 | filing β |
| Financial Statements and Exhibits (9.01) | Apr 28, 2026 | filing β |
| Officer/director changes (5.02) | Mar 25, 2026 | filing β |
| Reg FD disclosure (7.01) | Mar 25, 2026 | filing β |
| Financial Statements and Exhibits (9.01) | Mar 25, 2026 | filing β |
| Earnings (2.02) | Feb 25, 2026 | filing β |
| Reg FD disclosure (7.01) | Feb 25, 2026 | filing β |
| Financial Statements and Exhibits (9.01) | Feb 25, 2026 | filing β |
| Reg FD disclosure (7.01) | Jan 12, 2026 | filing β |
| Financial Statements and Exhibits (9.01) | Jan 12, 2026 | filing β |
| Other events (8.01) | Dec 8, 2025 | filing β |
| Financial Statements and Exhibits (9.01) | Dec 8, 2025 | filing β |
| Other events (8.01) | Nov 26, 2025 | filing β |
| Financial Statements and Exhibits (9.01) | Nov 26, 2025 | filing β |
| Earnings (2.02) | Nov 4, 2025 | filing β |
| Officer/director changes (5.02) | Nov 4, 2025 | filing β |
| Reg FD disclosure (7.01) | Nov 4, 2025 | filing β |
| Financial Statements and Exhibits (9.01) | Nov 4, 2025 | filing β |
| Other events (8.01) | Oct 29, 2025 | filing β |